283 related articles for article (PubMed ID: 9357551)
1. Induction of specific-locus and dominant lethal mutations in male mice by 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU).
Ehling UH; Adler ID; Favor J; Neuhäuser-Klaus A
Mutat Res; 1997 Oct; 379(2):219-31. PubMed ID: 9357551
[TBL] [Abstract][Full Text] [Related]
2. Increased mutagenicity of chloroethylnitrosoureas in the presence of a rat liver S9 microsome mixture.
Suling WJ; Rice LS; Shannon WM
J Natl Cancer Inst; 1983 Apr; 70(4):767-9. PubMed ID: 6220173
[TBL] [Abstract][Full Text] [Related]
3. Capillary gas chromatography and thermionic N-P-specific detection of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) or 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) in stability and pharmacokinetic studies.
El-Yazigi A; Martin CR
Pharm Res; 1988 Apr; 5(4):220-5. PubMed ID: 3247301
[TBL] [Abstract][Full Text] [Related]
4. Relationship of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) pharmacokinetics of uptake, distribution, and tissue/plasma partitioning in rat organs and intracerebral tumors.
Levin VA; Kabra PA; Freeman-Dove MA
Cancer Chemother Pharmacol; 1978; 1(4):233-42. PubMed ID: 750110
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of nitrosoureas: comparison of 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) after oral and intravenous administration to rats.
Russo RG; Cattaneo MT; Bartosek I
Tumori; 1984 Dec; 70(6):499-502. PubMed ID: 6531792
[TBL] [Abstract][Full Text] [Related]
6. The effects of BCNU (1,3-bis(2-chloroethyl)-1-nitrosourea) and CCNU (1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea) on glutathione reductase and other enzymes in mouse tissue.
Maker HS; Weiss C; Brannan TS
Res Commun Chem Pathol Pharmacol; 1983 Jun; 40(3):355-66. PubMed ID: 6622814
[TBL] [Abstract][Full Text] [Related]
7. The effect of phenobarbital pretreatment on the antitumor activity of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) and 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl-1-nitrosourea (PCNU), and on the plasma pharmacokinetics and biotransformation of BCNU.
Levin VA; Stearns J; Byrd A; Finn A; Weinkam RJ
J Pharmacol Exp Ther; 1979 Jan; 208(1):1-6. PubMed ID: 759602
[TBL] [Abstract][Full Text] [Related]
8. Mutational fingerprint induced by the antineoplastic drug chloroethyl-cyclohexyl-nitrosourea in mammalian cells.
Inga A; Iannone R; Campomenosi P; Molina F; Menichini P; Abbondandolo A; Fronza G
Cancer Res; 1995 Oct; 55(20):4658-63. PubMed ID: 7553645
[TBL] [Abstract][Full Text] [Related]
9. In vivo chemosensitization by misonidazole in sensitive and resistant tumor lines.
Mulcahy RT; Siemann DW
Cancer Res; 1983 Oct; 43(10):4709-13. PubMed ID: 6883329
[TBL] [Abstract][Full Text] [Related]
10. Interference with effects of amphotericin B on Candida albicans cells by 2-chloroethyl-1-nitrosoureas.
Brajtburg J; Elberg S; Kobayashi GS; Medoff G
Antimicrob Agents Chemother; 1988 Mar; 32(3):327-30. PubMed ID: 3284460
[TBL] [Abstract][Full Text] [Related]
11. An analysis of 1-(2-chloroethyl)-1-nitrosourea activity at the cellular level.
Weinkam RJ; Dolan ME
J Med Chem; 1983 Nov; 26(11):1656-9. PubMed ID: 6226795
[TBL] [Abstract][Full Text] [Related]
12. Tumorigenic effect of topical mechlorethamine, BCNU and CCNU in mice.
Zackheim HS; Smuckler EA
Experientia; 1980 Oct; 36(10):1211-2. PubMed ID: 7418808
[TBL] [Abstract][Full Text] [Related]
13. Role of O6-methylguanine-DNA methyltransferase in the resistance of pancreatic tumors to DNA alkylating agents.
Kokkinakis DM; Ahmed MM; Delgado R; Fruitwala MM; Mohiuddin M; Albores-Saavedra J
Cancer Res; 1997 Dec; 57(23):5360-8. PubMed ID: 9393761
[TBL] [Abstract][Full Text] [Related]
14. Phase II study of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU; NSC-79037) in the treatment of brain tumors.
Fewer D; Wilson CB; Boldrey EB; Enot JK
Cancer Chemother Rep; 1972 Jun; 56(3):421-7. PubMed ID: 19051504
[TBL] [Abstract][Full Text] [Related]
15. Use of phenobarbital and high doses of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in the treatment of brain tumor-bearing mice.
Muller PJ; Tator CH; Bloom ML
Cancer Res; 1983 May; 43(5):2068-71. PubMed ID: 6831437
[TBL] [Abstract][Full Text] [Related]
16. Induction of dominant lethal mutations by Ascaris trypsin inhibitor in male mice.
Blaszkowska J
Reprod Toxicol; 2010 Jan; 29(1):113-9. PubMed ID: 19737609
[TBL] [Abstract][Full Text] [Related]
17. Lysis of human promyelocytic HL-60 cells by amphotericin B in combination with 2-chloroethyl-1-nitrosoureas: role of the carbamoylating activity of nitrosoureas.
Brajtburg J; Elberg S; Schechtman KB; Medoff G
Cancer Res; 1990 Jun; 50(11):3274-8. PubMed ID: 2334920
[TBL] [Abstract][Full Text] [Related]
18. Autologous bone marrow grafts in dogs treated with lethal doses of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.
Abb J; Netzel B; Rodt HV; Thierfelder S
Cancer Res; 1978 Jul; 38(7):2157-9. PubMed ID: 350384
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of action of (2-haloethyl)nitrosoureas on DNA. Isolation and reactions of postulated 2-(alkylimino)-3-nitrosooxazolidine intermediates in the decomposition of 1,3-bis(2-chloroethyl)-, 1-(2-chloroethyl)-3-cyclohexyl-, and 1-(2-chloroethyl)-3-(4'-trans-methylcyclohexyl)-1-nitrosourea.
Lown JW; Chauhan SM
J Med Chem; 1981 Mar; 24(3):270-9. PubMed ID: 7265113
[TBL] [Abstract][Full Text] [Related]
20. Induction of specific-locus and dominant lethal mutations in male mice by 1-methyl-1-nitrosourea (MNU).
Ehling UH; Neuhäuser-Klaus A
Mutat Res; 1991; 250(1-2):447-56. PubMed ID: 1944358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
